Uppsala, Sweden, Sept. 12, 2023 (GLOBE NEWSWIRE) Eurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision medicine programs UPPSALA, Sweden, 12th September, 2023 (GLOBE NEWSWIRE) Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the collaboration with Eurofins Genomics to bolster its offerings in the fields of research, population health, and regulated clinical trials through the application of Olink technology. The Olink platform rep
/PRNewswire/ The "Testing Laboratories: Global Strategic Business Report" report has been added to ResearchAndMarkets.com s offering. The global market for.
/PRNewswire/ The "Global Mycoplasma Diagnostics Market (2022-2027) by Type, Technique, Application, End-user, and Geography, Competitive Analysis and the.